Search

Jay Reilly represents biotech, medical device and diagnostic companies, as well as universities and nonprofits, in strategic transactions in the life sciences industry, particularly complex collaborative arrangements and technology acquisitions and dispositions. Jay has extensive experience...

For more than 25 years, Michael Gold has assisted clients in a wide variety of industries in corporate and transactional matters. He is a trusted advisor to general counsel, senior management and boards of directors across the country. Michael is a "closer" with a record of negotiating complex...

A patent attorney with a Ph.D. in Molecular Biology and Microbiology, Alireza Behrooz assists companies and universities in protecting intellectual property connected to inventions in the life sciences. Drawing on years of private practice experience, Alireza prepares, files and secures patents as...

Jason McElroy is a trial lawyer with nearly 20 years of experience representing clients in complex litigation in federal and state courts. He has obtained verdicts and judgments in jury trials, bench trials and arbitration proceedings throughout the country. Jason litigates a wide range of matters...

Max Bremer advises entrepreneurs and established companies on key transactions throughout the business life cycle, from formations and financings to mergers, acquisitions and divestitures. Max works with clients in a variety of industries, including health care IT, medical devices, data analytics...

Doug Ramler's focus is on helping entrepreneurs, managers and boards build their companies. He advises high-growth start-up and emerging companies on business formation, technology commercialization, finance, governance, contracts and strategic matters. With 30 years of experience, Doug is able to...

Counsel From the Earliest Stage of Development Through Disposition of Projects Throughout the continuum of financing, acquiring, developing, leasing and selling real estate are a multitude of complexities to address and challenges to overcome—from regulatory hurdles and shifting capital stacks to...